Srinroch, C.; Sahakitpichan, P.; Chimnoi, N.; Ruchirawat, S.; Kanchanapoom, T. Flavonol Triglycosides from Magnolia utilis. Phytochem. Lett. 2019, 29, 57-60.

28 Dec 2019
0
0

Srinroch, C.; Sahakitpichan, P.; Chimnoi, N.; Ruchirawat, S.; Kanchanapoom, T. Flavonol Triglycosides from Magnolia utilis. Phytochem. Lett. 2019, 29, 57-60.

Tags

Share this

Related Posts

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290
26 Jan 2021
0

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290

One Health drivers of antibacterial resistance: Quantifying the relative impacts of human, animal and environmental use and transmission. Booton RD, Meeyai A, Alhusein N, Buller H, Feil E, Lambert H, Mongkolsuk S, Pitchforth E, Reyher KK, Sakcamduang W, Satayavivad J, Singer AC, Sringernyuang L, Thamlikitkul V, Vass L; OH-DART Study Group, Avison MB, Turner KME. One Health. 2021 Jan 26;12:100220. doi: 10.1016/j.onehlt.2021.100220. eCollection 2021 Jun. PMID: 33644290
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More